Exhibit 99.2
This Statement on Form 4 is filed by: (i) John D. Shulman, (ii) JCP III SM AIV, L.P., (iii) METP Holdings, LLC, (iv) Juggernaut Partners III GP, L.P., and (v) Juggernaut Partners III GP, Ltd.
Name of Designated Filer: John D. Shulman
Date of Event Requiring Statement: October 18, 2021
Issuer Name and Ticker or Trading Symbol: Petros Pharmaceuticals, Inc. [PTPI]
| John D. Shulman |
| | |
| | /s/ John D. Shulman |
| | |
| METP Holdings, LLC |
| | |
| By: | Juggernaut Partners III GP, L.P., |
| | its general partner |
| | By: Juggernaut Partners III GP, Ltd. its general partner |
| | |
| | By: /s/ John D. Shulman |
| | Name: John D. Shulman Title: Director |
| JCP III SM AIV, L.P. |
| | |
| By: | Juggernaut Partners III GP, L.P., |
| | its general partner |
| | By: Juggernaut Partners III GP, Ltd. its general partner |
| | |
| | By: /s/ John D. Shulman |
| | Name: John D. Shulman Title: Director |
| | |
| Juggernaut Partners III GP, L.P. |
| | |
| By: | Juggernaut Partners III GP, Ltd. |
| | its general partner |
| | | |
| | By: | /s/ John D. Shulman |
| | Name: | John D. Shulman |
| | Title: | Director |
| | |
| | |
| Juggernaut Partners III GP, Ltd. |
| | |
| By: | /s/ John D. Shulman |
| Name: | John D. Shulman |
| Title: | Director |